Drug
Neo PV 01
Neo PV 01: highest development phase Phase 1, developed by BioNTech. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| NEO-PV-01 NCT02897765 | Phase 1 | Urinary Bladder Cancer |
| NEO-PV-01 NCT03597282 | Phase 1 | Metastatic Melanoma |
Latest
No recent events.
Follow Neo PV 01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.